GoldenGolden
Advanced Search
Adnexus Therapeutics

Adnexus Therapeutics

Adnexus Therapeutics is a biotechnology company founded by Noubar Afeyan.

Adnexus Therapeutics, founded in 2003,and acquired by Bristol-Myers Squibb was a biopharmaceutical company focused on the development and commercialization of Adnectins as a class of therapeutics based on human fibronectin.

Timeline

August 2007
Adnexus Therapeutics raises a $15,500,000 series B round from Atlas Venture, Flagship Pioneering, HBM Healthcare Investments AG, Polaris Partners and Venrock.
June 2006
Adnexus Therapeutics raises a $27,000,000 series B round from Atlas Venture, Flagship Pioneering, Polaris Partners and Venrock.
March 2003
Adnexus Therapeutics raises a $13,000,000 series A round from Atlas Venture, Flagship Pioneering and Polaris Partners.
October 28, 2002
Adnexus Therapeutics was founded by Gordon Wong and Noubar Afeyan.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.